PCN285 THERAPEUTIC BENEFIT OF ORPHAN DRUGS IN ONCOLOGY: EVIDENCE AT THE POINT OF EUROPEAN MARKETING AUTHORISATION
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.480
https://www.valueinhealthjournal.com/article/S1098-3015(19)32858-X/fulltext
Section Title :
Section Order :
10405
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32858-X&doi=10.1016/j.jval.2019.09.480